(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
2.68% $ 1.530
Live Chart Being Loaded With Signals
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function...
Stats | |
---|---|
Dzisiejszy wolumen | 108 345 |
Średni wolumen | 300 132 |
Kapitalizacja rynkowa | 42.80M |
EPS | $0 ( 2024-05-02 ) |
Następna data zysków | ( $-0.460 ) 2024-06-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.680 |
ATR14 | $0.0180 (1.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-29 | Shaw Kevin G. | Buy | 93 900 | Employee Stock Option (Right to Buy) |
2024-03-29 | Richman Michael | Buy | 244 400 | Employee Stock Option (Right to Buy) |
2024-03-29 | Myint Han | Buy | 93 900 | Employee Stock Option (Right to Buy) |
2024-03-29 | Mayer Timothy | Buy | 93 900 | Employee Stock Option (Right to Buy) |
2024-03-29 | Langermann Sol | Buy | 93 900 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 6 167 538 | Sell: 82 463 |
Wolumen Korelacja
NextCure Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
EUSGU | 0.89 |
NOTV | 0.875 |
NICE | 0.865 |
DRRX | 0.847 |
GRBK | 0.845 |
MURFU | 0.844 |
PCAR | 0.839 |
VSMV | 0.832 |
QMCO | 0.83 |
DALI | 0.829 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NextCure Inc Korelacja - Waluta/Towar
NextCure Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-3.68M (0.00 %) |
EPS: | $-2.25 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-3.68M (0.00 %) |
EPS: | $-2.25 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-4.48M (0.00 %) |
EPS: | $-2.50 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.51 |
Financial Reports:
No articles found.
NextCure Inc
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej